Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 1 - 1 of 1 results for "Myricx Bio"

Super funds to reap returns from $2.2bn biotech exit

RIDDHIMA TALWANI  |  TUESDAY, 7 JUL 2026
Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn). The exit will generate a significant return for investors, Brandon Capital ...
PAGE:
1